This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Up in Smoke? The Effects of Marijuana Legalization

TheStreet Premium Services

A complimentary preview
of Options-Profits Previews

Options Course: On Saturday, December 1, the CBOE, Option Pit and OptionsProfits are hosting a full-day class, Using Volatility to Improve Directional Trading CLICK HERE FOR INVITE AND TO REGISTER.

Does the move toward legalization of marijuana pose a threat to the for-profit prison industry?

On November 6th, voters in Colorado and Washington passed referenda legalizing the recreational use of marijuana. It is not clear yet how federal enforcement officials will respond to the new laws in practice, or whether the move toward legalization is the start of a larger trend. But if we see similar reforms gain traction in future elections in other states, it could affect the fortunes of several public companies. And not just Yum! Brands (YUM) and Pepsi (PEP).

For companies like Corrections Corporation of America (CXW) and GEO Group (GEO), the downside risk to marijuana legalization could be substantial. Recent reports from the analyst community make general mentions of policy changes as an ongoing risk factor, but make no specific mention of changes to drug laws. SunTrust cited the risk of "change s in state or federal policies and funding that reduce inmate populations," and a post-election report from Macquarie included similar language. Otherwise, analysts are very positive on the stock, and are focused mostly on the company's short-term plans to convert to a real estate investment trust. During the Q3 earnings call on November 8, an analyst asked about a referendum in California to reclassify some "three strikes" inmates, but no other policy changes were mentioned.

While changes in drug policy have not been a focus of industry analysts, CXW itself is more straightforward; each year's 10-K filing with the SEC includes the following in the "Risk Factors" section:

"The demand for our facilities and services could be adversely affected by the relaxation of enforcement efforts, leniency in conviction or parole standards and sentencing practices or through the decriminalization of certain activities that are currently proscribed by criminal laws. For instance, any changes with respect to drugs and controlled substances or illegal immigration could affect the number of persons arrested, convicted, and sentenced, thereby potentially reducing demand for correctional facilities to house them." **

That is, fewer people in prison because of drug charges would mean lower profits for companies in the prison business. As the largest private owner of prisons in the U.S., CCA operates 66 facilities housing 91,000 beds. The company manages 45% of the for-profit prison space under contract with state and federal governments. And while the company has some revenue from prison transport operations and from income related to its real estate holdings, the vast majority of revenues come from housing inmates.

Drug policy may actually be the key driver of profits for the prison industry. A study released in September from the U.S. Government Accountability Office found that growth in the federal prison population was outpacing prison capacity, and that the main drivers of overcrowding were the drug war and especially harsh federal drug sentencing. And marijuana-related charges are a big part of that picture: 2007 data from the Department of Justice showed that marijuana possession charges comprised more than 42% of federal drug charges (another 5% were for sale and manufacture), and that marijuana arrests were rapidly outpacing all other drugs.

fig. 1. Number of arrests by drug type, 1982-2007. Source: U.S. Department of Justice



Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Partners Compare Online Brokers

Top Rated Stocks Top Rated Funds Top Rated ETFs